Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Qualcomm Stock Is Poised to Benefit From 5G Growth

Investors have had few reasons to buy QCOM stock over the last few years, but thanks to 5G, QCOM looks poised to begin a huge growth phase.

7 AI Stocks to Buy to Profit from the Recent Tech Correction

Artificial intelligence will power many of the next decade's biggest advances. Here are seven AI stocks that will help you ride the wave.

Advanced Micro Devices Stock Is Still a Star Within a Strong Sector

Don't count on an earnings beat, but AMD stock should do well in the long run. And depending on how you look at it, it's cheaper than some of its competition.

Management Holding Steady Is the Right Move for Micron Stock

After years of struggling to keep up with rivals, Micron has finally got its act together in the DRAM segment. But with its passive approach to EUV lithography, is MU stock at risk of falling behind again?

Next Week Will Be a Game-Changer for AT&T Stock

AT&T stock will have a big week next week when it reports third-quarter earnings and holds its HBO Max investor event. T stock is a great value with a string dividend and plenty of catalysts ahead.

There Are at Least 3 Great Reasons to Buy Yeti Stock

Yeti earnings have surprised for each of the last four quarters, it’s unlikely to disappoint when it announces October 31.

Dumping Aphria Stock over Profit Concerns Is a Huge Mistake

t seems investors have no clue what they want from cannabis stocks these days. That’s really bad news for anyone expecting to profit from APHA stock or any of the other Canadian producers.

Go Long on Amazon Stock Regardless of Earnings

For Amazon stock, the recent Q3 earnings miss is just noise. The real catalyst is the company’s constant search for domination and disruptions.

Is Walmart Stock a Buy Ahead of the Mid-November Earnings Report?

In the next earnings report, Walmart stock investors would like to see that management is successful in striking a healthy equilibrium between physical stores and online retail sales

Investors Should Short JNJ Stock and Buy Boeing Stock

The market seems to be giving JNJ stock a pass while hitting Boeing stock hard. It should be doing the opposite.

Timing is Everything When Sizing Up a Shopify Stock Entry Point

Shopify stock could have some short-term upside in it, but SHOP stock may make new lows for a better long-term entry.

5 Reasons Why I Still Believe in Hexo Stock

2019 has been rough on cannabis-based investments, and Hexo stock has taken the brunt of the volatility. Still, despite the extreme ugliness, there are multiple longer-term bullish factors to consider.

Aphria Stock Looks Like the Best Cannabis Play Right Now

Aphria stock, like other cannabis stocks, has plunged. But while risks remain, APHA stock looks attractive here.

7 Top-Notch REITs to Buy for Income

Don't get hung up on failing mall REITs. These seven are great stocks to buy with strong growth prospects and juicy dividends.

Tilray Stock Short Sellers Need to Be Careful

Tilray has been one of the most profitable cannabis stocks to short in the past year. However, shorting TLRY stock at this point is a dangerous play.

7 Cybersecurity Stocks to Keep Your Portfolio Safe

Figuring out which stocks to buy is always a challenge. That said, with the cybersecurity industry, you’re dealing with a market that will only increase in demand and relevancy.

Electronic Arts Stock Has a Long Runway for Growth

Electronic Arts stock is trying to break out of a tight range. Some opportunities both now, and in the future, should create opportunities.

Nike Stock Looks Like a Winner With New, Tech-Focused CEO

Nike has a new CEO and that's great for investors. With a focus on digital growth, the new leadership at NKE could be exactly what it needs.

One Step Closer to a Medical Game Changer

We don’t get many chances to invest in a once-in-a-lifetime, game-changing medical breakthrough. We need to take full advantage.